Navigation Links
Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
Date:3/6/2008

IRVINE, Calif., March 6 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), announced that the company will release its earnings for the fourth quarter and full year ended December 31, 2007 prior to market open on Tuesday, March 25, 2008. The company also said that President Richard P. Lanigan and Senior Vice President and Chief Financial Officer William R. Abbott will host an investor conference call that day at 12:00 p.m. Eastern time (9:00 a.m. Pacific time) to review the company's financial results and business outlook.

The call is open to all interested investors through a live audio web broadcast via the Internet at http://www.cardiogenesis.com and will also be available by dialing (800) 901-5241. The participant passcode is 15597145. The call will be archived on the company's web site and will be available for playback for seven days beginning shortly after the live webcast.

About Cardiogenesis Corporation

Cardiogenesis is a medical device company specializing in the treatment of cardiovascular disease and is a leader in devices that stimulate cardiac angiogenesis. The company's market leading Holmium: YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease. Surgical products and accessories for the company's minimally invasive Percutaneous Myocardial Channeling (PMC) procedure are currently being marketed in Europe and other international markets.

For more information on the company and its products, please visit the Cardiogenesis company website at

SOURCE Cardiogenesis Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
2. Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th
3. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
4. AMERIGROUP Corporation to Present at the Lehman Brothers Global Healthcare Conference on March 20
5. Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008
6. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
7. Longs Drug Stores Corporation Declares Cash Dividend on Common Shares
8. Met-Pro Corporations Systems Division Receives Equipment Order Totaling Approximately $600,000
9. Zix Corporation Celebrates National Patient Safety Awareness Week with Continued Success in e-Prescribing
10. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
11. Senior Lifestyle Corporation Names John Cobb as President and CEO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., , DALLAS, Nov. 27 /PRNewswire-USNewswire...edical procedure only 25 years ago, solid organ tr...ation thanks to the extraordinary men and women wh...n Nov. 11. Leaders came together from medical cent...sary of Baylor Regional Transplant Institute (BRTI...
(Date:11/27/2009)... XenaCare Holdings has an...he Arthritis Foundation, one of the largest nonpro...and public health education. , ...- XenaCare Holdings, Inc. (OTCBB: XCHO), a company...tion of consumer healthcare products, has announce...
(Date:11/27/2009)... Multi-purpose bilingual ... Designed for use by the business community to edu...ety of subjects from Safety issues to Dinosuars to... Saint Louis, MO (PRWEB) November 27, 2... electronics or toys to keep them busy any hour of...
(Date:11/26/2009)... In the next 25 years, the number of Americans li...from 23.7 million in 2009 to 44.1 million in 2034....lmost triple, rising from $113 billion to $336 bil...besity, researchers based at the University of Chi...e . , The number of those with diabetes covered ...
(Date:11/26/2009)... Dr. David Kim of the Liv...oss surgery in Dallas , is one of a growing number...r social networking sites to connect with individu...atment to fight morbid obesity. Dr. Kim is utilizi...nformation about his practice with the community. ...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
... that zolpidem, temporarily improved brain functio... patient was able to communicate// , walk, and eat... bout of insomnia. Zolpidem is a drug norma...he March 2007 issue of Annals of Neurology (http:/...
...abourers of a Bihar village affected by Kala Azar,...rnment's plan// to check the spread of the deadly ...k and mortar is all set to become a reality for th...hey will be provided houses by the central governm...
...ers and seamstresses, cheer up. That stinging pain...rience in your wrists//, may not be a result of ca...TS, more often than not, leads one straight to the... CTS happens when a nerve passing through your ...
...n Infant Death Syndrome (SIDS), the third leading ...use of a pacifier//. According to an article in Nu...ctitioners should counsel new parents on the poten...orce on SIDS, suggesting that pacifier use be enco...
...,' or baseline condition when the brain is idling,...zophrenia and this aberrant activity// may be caus...Yale School of Medicine researcher reports. ...lly abnormal in patients with schizophrenia, also ...
...d to be passed in South Carolina, which will enabl...onate their kidneys//. If this bill is passed, the... jail by as many as 180 days. Democratic Senat...n donors. According to ABC report there are around...
Other Medicine News:Health News:Zolpidem Might Assist Patients With Akinetic Mutism 2Health News:Harbinger of Hope for Kala Azar Victims of Bihar 2Health News:Computer Programmers, need not fear Carpal Tunnel Syndrome 2Health News:Brain’s "Default Mode" Awry in Schizophreni 2
(Date:11/25/2009)..., N.J., Nov. 25 Pharmass...ceutical company committed to discovering, develop... infections, reported financial results for the fi...0, 2009 Pharmasset held $58.4 million in cash, cas...Pipeline Update and 2009 Highlights ,, RG7128...
(Date:11/25/2009)..., N.J., Nov. 25 The FDA granted tr...) tablets, a non-nucleoside reverse transcriptase ...cifically indicated for use in treatment-experienc...ith HIV-1 strains resistant to an NNRTI and other ...oval is based on 48-week data from two Phase 3 stu...
(Date:11/25/2009)...IDGE, N.J., Nov. 25 Regado Bioscie...ment of antithrombotic aptamers with active contro... President, will be presenting at the Piper Jaffra...rk Palace Hotel in New York City. Dr. Mazzo,s pre..., December 1 and will include an overview of the C...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Nepali Home Minister Commends Narconon International for Saving Lives 56495 1Nepali Home Minister Commends Narconon International for Saving Lives 56495 2Helix BioPharma Closes Private Placement 13918 1Helix BioPharma Closes Private Placement 13918 2Helix BioPharma Closes Private Placement 13918 3JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 1JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 2JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 3JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 4JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 5
...product in,AM-Pharma,s pipeline , BUNNIK, The Neth...armaceutical company developing novel therapeutics...day announced positive,results in patients with Ac...bgroup of a Phase IIa trial with Alkaline Phosphat..., a marker for renal function,improved by 45% (me...
...Institut (SSI) and Intercell, report promising d...tuberculosis (TB) subunit vaccine , , » ... Intercell’s,adjuvant IC31™ , , &raq...e European Union aims to,either , replace t...almette vaccine” or,to , boost its ac...
Other Medicine Technology:AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 2AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 2Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 4
...ucts for autoimmune testing feature single-well AN...c reflex tests including dsDNA, and 6 individual E...and Jo-1. In addition, our autoimmune ELISA family... (IgA, IgG, IgM), Thyroglobulin, Thyroid Microsoma...
Suture Ring
Digital ClearField Lens
Crypto-LA® Cryptococcal Antigen Test
Medicine Products: